Search

everythinglearnresearchcommunity

for

Search:↓

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Analog 23 is a promising compound for prostate cancer treatment.

The HCR gene contributes to psoriasis risk.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Injecting specific oligonucleotides can change hair growth and structure by altering a gene.

A genetic marker linked to a type of hair loss was found in most patients studied.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Researchers developed a method to identify and analyze cyclosporin compounds and their structures effectively.

Certain gene changes and hormone levels are linked to female hair loss.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

A new mouse gene, Keratin 17n, is mainly found in nail tissue and may explain why mice without Keratin 17 don't have nail issues.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

A new compound that could treat various androgen-related conditions was created and analyzed.

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Clofazimine may be effective for treating ashy dermatosis.